Stay updated on IGNITE DMD Gene Transfer Clinical Trial
Sign up to get notified when there's something new on the IGNITE DMD Gene Transfer Clinical Trial page.

Latest updates to the IGNITE DMD Gene Transfer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe study protocol for SGT-001 has been updated to drop the control arm and now focuses solely on active treatment for participants. Additionally, the timeline for primary and secondary outcome measures has been clarified, with specific endpoints related to safety and efficacy over 12 months and 5 years.SummaryDifference32%
- Check23 days agoChange DetectedThe page has undergone significant content changes regarding the clinical study of Duchenne Muscular Dystrophy (DMD), with the removal of detailed study protocols and criteria, and the addition of a new revision number.SummaryDifference22%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 6, 2025. However, there are no significant changes to core content, pricing, or availability.SummaryDifference0.7%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe webpage has updated its service availability notice, indicating that some NLM-NCBI services are experiencing heavy traffic, which may impact performance. Additionally, several dates have been added and removed from the page.SummaryDifference3%
Stay in the know with updates to IGNITE DMD Gene Transfer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNITE DMD Gene Transfer Clinical Trial page.